###begin article-title 0
###xml 43 48 <span type="species:ncbi:9606">human</span>
Regulation of carboxylesterase 1 (CES1) in human adipose tissue
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Abstract
###end title 2
###begin p 3
###xml 254 255 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 268 270 268 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 280 283 280 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;18</sup>
###xml 299 300 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 313 315 313 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 414 416 414 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 445 447 445 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 504 505 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 554 556 554 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 674 676 674 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 738 740 738 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 750 752 750 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 141 146 <span type="species:ncbi:9606">human</span>
Carboxylesterase 1 (CES1) has recently been suggested to play a role in lipolysis. Our aim was to study the regulation of CES1 expression in human adipose tissue. In the SOS Sib Pair Study, CES1 expression was higher in obese compared with lean sisters (n = 78 pairs, P = 8.7 x 10-18) and brothers (n = 12 pairs, P = 0.048). CES1 expression was higher in subcutaneous compared with omental adipose tissue in lean (P = 0.027) and obese subjects (P = 0.00036), and reduced during diet-induced weight loss (n = 24, weeks 8, 16, and 18 compared to baseline, P < 0.0001 for all time points). CES1 expression was higher in isolated adipocytes compared with intact adipose tissue (P = 0.0018) and higher in large compared with small adipocytes (P = 4.1 x 10-6). Basal and stimulated lipolysis was not different in individuals with high, intermediate, and low expression of CES1. Thus, CES1 expression was linked to body fat and adipocyte fat content but not to lipolytic activity.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 129 132 129 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr">[1]</xref>
###xml 180 183 180 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">[2]</xref>
###xml 214 217 214 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3" ref-type="bibr">[3]</xref>
###xml 360 363 360 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">[4]</xref>
###xml 573 576 573 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5" ref-type="bibr">[5]</xref>
Obesity is associated with the development of metabolic syndrome, a major risk factor for cardiovascular morbidity and mortality [1]. Obesity treatment improves metabolic function [2] and reduces overall mortality [3]. The negative energy balance during a hypocaloric diet is known to profoundly modify adipocyte metabolism, particularly the lipolytic pathway [4]. Lipolysis, the process leading to breakdown of triglycerides into fatty acids and glycerol, requires the activities of TG lipases, mainly hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) [5].
###end p 6
###begin p 7
###xml 260 263 260 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6" ref-type="bibr">[6]</xref>
###xml 450 458 450 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 458 461 458 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr">[7]</xref>
###xml 526 529 526 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr">[8]</xref>
###xml 272 277 <span type="species:ncbi:10090">mouse</span>
###xml 365 370 <span type="species:ncbi:9606">human</span>
###xml 522 525 <span type="species:ncbi:9606">man</span>
The mammalian CES genes are members of the serine esterase family and the encoded proteins are localized in the endoplasmic reticulum (ER) of many tissues. These enzymes efficiently catalyze the hydrolysis of a variety of ester- and amide-containing chemicals [6]. In the mouse, carboxylesterase 3 (CES3; also called triacylglycerol hydrolase; TGH), the homolog of human CES1, is responsible for a major fraction of adipose tissue lipolytic activity in vitro[7], and it has also been suggested that CES1 is a TG lipase in man [8], however evidence is lacking.
###end p 7
###begin p 8
###xml 56 61 <span type="species:ncbi:9606">human</span>
The aim of this study was to examine CES1 expression in human adipose tissue in relation to obesity, weight loss, adipocyte size, adipose tissue location, and lipolysis.
###end p 8
###begin title 9
Materials and methods
###end title 9
###begin p 10
###xml 415 421 415 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9 bib10" ref-type="bibr">[9,10]</xref>
###xml 515 519 515 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr">[11]</xref>
All study subjects received written and oral information before giving written informed consent. The regional Ethics Committee in Gothenburg, at the Karolinska University Hospital and the South Birmingham Ethics Committee approved these studies. Blood samples and adipose tissue biopsies were taken after an overnight fast. Biochemical and anthropometrical measurements and examinations were performed as described [9,10]. Computerized tomography (CT) was used to determine body composition as previously described [11].
###end p 10
###begin title 11
Subjects and samples
###end title 11
###begin p 12
###xml 0 36 0 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Very low calorie diet (VLCD) studies</italic>
###xml 407 411 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">[12]</xref>
###xml 78 83 <span type="species:ncbi:9606">women</span>
###xml 91 94 <span type="species:ncbi:9606">men</span>
###xml 369 377 <span type="species:ncbi:9606">patients</span>
Very low calorie diet (VLCD) studies. Twenty-four unrelated obese subjects, 6 women and 18 men, were given VLCD (450 kcal/day) for 16 weeks followed by gradual reintroduction of a normal diet. Abdominal subcutaneous adipose tissue biopsies and fasting blood samples were obtained before (week 0), during (weeks 8 and 16), and after (week 18) treatment. On average, the patients lost 27.7 kg during the diet [12]. Microarray analysis was performed individually in all 24 subjects at all time points. For verification by real-time PCR, abdominal subcutaneous adipose tissue biopsies were obtained from 10 additional subjects at baseline, after 8 and 18 weeks of VLCD.
###end p 12
###begin p 13
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The SOS Sib Pair Study</italic>
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The SOS Sib Pair Study. The SOS Sib Pair Study consists of 154 nuclear families with BMI-discordant sib pairs (BMI difference â©¾ 10 kg/m2) resulting in a study population consisting of 732 subjects. Microarray expression analysis was performed in the offspring cohort. Normalization was performed using MAS 5.0 (Affymetrix, Santa Clara, CA). For correlations, results from 357 microarrays were included. However, for comparisons between lean and obese siblings, gender discordant pairs were excluded and only the most BMI-discordant sib pair in each family was included, resulting in 78 pairs of sisters and 12 pairs of brothers.
###end p 13
###begin p 14
###xml 0 56 0 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Paired abdominal subcutaneous and omental adipose tissue</italic>
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 544 545 538 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 575 576 567 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 150 158 <span type="species:ncbi:9606">patients</span>
Paired abdominal subcutaneous and omental adipose tissue. Paired abdominal subcutaneous and omental (n = 10) adipose tissue was collected from female patients (age 45.4 +/- 9.2 years; mean +/- SD) undergoing elective surgery (liposuction and elective gynecological procedures), in accordance with guidelines of the South Birmingham Ethics Committee. Smokers and subjects with recent weight change, hormone replacement, and malignant diseases were excluded. The subjects were divided into two groups according to BMI (lean, BMI 23.0 +/- 1.2 kg/m2; obese, BMI 33.2 +/- 3.1 kg/m2; mean +/- SE). Microarray analysis was performed individually on samples from all 10 subjects.
###end p 14
###begin p 15
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Large and small adipocytes</italic>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">[13]</xref>
Large and small adipocytes. Needle biopsies of subcutaneous abdominal adipose tissue were obtained from 3 (microarray analysis) and 5 healthy volunteers (real-time PCR analysis), and small and large adipocytes were isolated as previously described [13].
###end p 15
###begin p 16
###xml 0 45 0 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Isolated adipocytes and intact adipose tissue</italic>
###xml 286 290 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">[14]</xref>
Isolated adipocytes and intact adipose tissue. Subcutaneous abdominal adipose tissue biopsies were obtained by needle aspirations in 14 subjects. A fraction was immediately frozen at -70 degreesC, and from the remaining adipose tissue, adipocytes were isolated by collagenase digestion [14]. RNA was prepared and real-time PCR analysis was performed on isolated adipocytes and intact adipose tissue.
###end p 16
###begin p 17
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Studies of lipolysis</italic>
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 400 404 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">[15]</xref>
###xml 821 822 801 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1142 1146 1122 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">[15]</xref>
###xml 1208 1209 1187 1188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 117 122 <span type="species:ncbi:9606">women</span>
###xml 679 685 <span type="species:ncbi:9913">bovine</span>
Studies of lipolysis. Subcutaneous abdominal adipose tissue biopsies were obtained by needle aspirations in 81 obese women under local anesthesia (BMI 31-53 kg/m2 and age 21-63 years). A fraction (300 mg) was immediately frozen at -70 degreesC and used for subsequent mRNA analysis, and the remaining tissue was used for lipolysis studies. The lipolysis assay has previously been described in detail [15]. In brief, a diluted suspension of isolated fat cells (about 5000-10,000 cells/ml) was incubated for 2 h in duplicate with air as the gas phase at 37 degreesC in Krebs-Ringer phosphate buffer (pH 7.4) supplemented with glucose (8.6 mumol/ml), ascorbic acid (0.1 mg/ml), and bovine serum albumin (20 mg/ml) in the absence (basal) or presence of increasing concentrations noradrenaline (a non-selective beta- and alpha2-adrenoreceptor agonist) or insulin. 8-Bromo-cyclic AMP (1 mmol/l, phosphodiesterase non-resistant cyclic AMP analogue) was added in the insulin experiments in order to magnify the antilipolytic effect of insulin. After the incubation, glycerol was measured in the media (lipolysis index) using a bioluminescence method [15]. The rate of lipolysis was expressed as mumol glycerol per 107 cells per 2 h. Basal and 8-bromo-cyclic AMP-affected glycerol release and the glycerol release at the maximum effective concentration for noradrenaline and insulin were calculated.
###end p 17
###begin title 18
RNA preparation and DNA microarray analysis
###end title 18
###begin p 19
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">[16]</xref>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 328 331 328 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">260</sub>
###xml 332 333 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 333 336 333 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">280</sub>
###xml 687 690 687 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9" ref-type="bibr">[9]</xref>
###xml 505 510 <span type="species:ncbi:9606">Human</span>
Total RNA from adipose tissue was prepared with Qiagen Lipid tissue kit (Qiagen, Hilden, Germany). Total RNA from adipocytes was prepared with the phenol-chloroform extraction method of Chomczynski and Sacchi [16]. After further purification with RNeasy (Qiagen), the RNA concentration was measured spectrophotometrically. The A260/A280 ratio was 1.8-2.0 and the quality of the RNA was verified by agarose gel electrophoresis before reverse transcription into cDNA. Gene expression was measured using the Human Genome U133A or U133Plus2.0 DNA microarray (Affymetrix). Preparation of cRNA and hybridization was performed according to standard Affymetrix protocols as previously described [9].
###end p 19
###begin title 20
Real-time PCR analysis of gene expression
###end title 20
###begin p 21
Reagents for real-time PCR analysis of CES1 and the reference genes LDL receptor-related protein 10 (LRP10) and 18S rRNA (Assays-on-Demand, TaqMan Reverse Transcriptase reagents, and TaqMan Universal PCR Master Mix) were from Applied Biosystems (Foster City, CA) and used according to the manufacturer's protocol. cDNA corresponding to 10 ng of RNA per reaction was used for real-time PCR analysis. Specific products were amplified and detected with the ABI Prism 7900HT Sequence Detection System (Applied Biosystems) using default cycle parameters. A standard curve obtained by serial dilution of pooled adipocyte cDNA was plotted for each primer-probe set. All standards and samples were analyzed in triplicate.
###end p 21
###begin title 22
Statistical analysis
###end title 22
###begin p 23
###xml 336 337 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr">[17]</xref>
###xml 559 563 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">[12]</xref>
###xml 366 372 <span type="species:ncbi:9606">person</span>
Correlations between CES1 expression and anthropometric and biochemical markers were performed using the Spearman rank correlation test. Differences in gene expression between cell populations were analyzed using the Wilcoxon signed-rank test. Differences in CES1 expression between lean and obese siblings were assessed using a paired T-test. Correlation of within person longitudinal measurements for the overall relations across the entire VLCD study duration was addressed through the use of generalized estimating equations [17], as previously described [12]. Values are expressed as mean +/- SD.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
Diet-induced weight loss
###end title 25
###begin p 26
###xml 148 150 148 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 163 165 163 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 189 195 189 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 335 337 335 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 347 353 347 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 496 498 496 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 510 512 510 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 536 542 536 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
DNA microarray analysis showed that CES1 expression was reduced in subcutaneous adipose tissue after 8 and 16 weeks of VLCD compared with baseline (P < 0.0001 and P < 0.0001, respectively, Fig. 1A). CES1 expression remained significantly reduced compared with baseline also after the 2 weeks of reintroduction to normal food (week 18; P < 0.0001; Fig. 1A). The reduced CES1 expression at weeks 8 and 18 compared to baseline was verified by real-time PCR in another 10 subjects treated with VLCD (P = 0.032 and P = 0.0057, respectively, Fig. 1B).
###end p 26
###begin p 27
###xml 291 298 291 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
CES1 expression levels in the VLCD study correlated with several anthropometric and biochemical parameters, including total adipose tissue, subcutaneous adipose tissue, OGTT insulin, cholesterol, low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol (HDL-C) (Table 1).
###end p 27
###begin title 28
Obesity-discordant siblings
###end title 28
###begin p 29
###xml 146 148 146 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 158 161 158 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;18</sup>
###xml 172 174 172 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#160;</italic>
###xml 183 189 183 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 435 442 435 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
In the SOS Sib Pair Study, obese females and males displayed higher CES1 expression compared with their lean siblings of the same gender (females P = 8.7 x 10-18 and males P = 0.048; Fig. 1C). CES1 expression levels correlated with several anthropometric and biochemical parameters, including BMI, waist, waist hip ratio, systolic blood pressure, diastolic blood pressure, OGTT, F-insulin, HOMA, cholesterol, LDL-C, HDL-C, and hs-CRP (Table 2).
###end p 29
###begin title 30
CES1 expression in adipose tissue depots and adipocytes
###end title 30
###begin p 31
###xml 87 88 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 203 204 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 222 223 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 233 239 233 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 369 370 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 381 383 381 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 428 429 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 439 445 439 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
CES1 expression was higher in isolated adipocytes compared with intact adipose tissue (P = 0.0018) and higher in subcutaneous compared with omental adipose tissue in both obese and lean subjects (obese, P = 0.00036; lean, P = 0.027; Fig. 1D). Moreover, CES1 expression was higher in large compared with small adipocytes from the same biopsy measured by DNA microarray (P = 4.1 x 10-6), and this was verified with real-time PCR (P = 0.046, Fig. 1E).
###end p 31
###begin title 32
CES1 expression in relation to lipolysis
###end title 32
###begin p 33
###xml 493 499 493 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
To examine the relation between CES1 expression and lipolysis, adipocytes from different individuals were divided into tertiles based on their relative CES1 expression measured by real-time PCR. There were no differences in either basal or 8b-cAMP-mediated lipolysis between samples with low, intermediate, and high CES1 expression. Moreover, both noradrenaline-stimulated and insulin-inhibited lipolysis was similar in samples with high, intermediate, and low expression levels of CES1 mRNA (Fig. 2A-D).
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 239 244 <span type="species:ncbi:9606">human</span>
###xml 426 431 <span type="species:ncbi:9606">human</span>
In this study, we investigated the regulation of CES1 expression in human adipose tissue and the relation between CES1 expression and TG lipolysis in adipocytes. Our results show that the expression of the CES1 gene is highly regulated in human adipose tissue, with increased levels in obese subjects and decreased levels during weight loss. However, there was no association between CES1 expression and lipolysis in isolated human adipocytes.
###end p 35
###begin p 36
###xml 175 178 175 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr">[8]</xref>
In our study, CES1 expression was markedly higher in adipose tissue from obese compared to lean subjects, which is in accordance with the results reported by Steinberg et al. [8]. In obese subjects, diet-induced weight loss resulted in decreased CES1 expression. During the VLCD study, CES1 expression correlated with total and subcutaneous adipose tissue mass measured by CT. CES expression was higher in adipocytes compared to whole adipose tissue, suggesting that the adipocyte is the main site of CES1 expression in adipose tissue. In addition, large adipocytes have higher CES1 expression compared with small adipocytes. Taken together, our results indicate that adipose tissue expression of CES1 is tightly linked to obesity, amount of body fat, and adipocyte fat content.
###end p 36
###begin p 37
###xml 127 130 127 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr">[7]</xref>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">[18]</xref>
###xml 924 931 924 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19 bib20 bib21 bib22" ref-type="bibr">[19&#8211;22]</xref>
###xml 987 991 987 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">[19]</xref>
###xml 1142 1146 1142 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">[19]</xref>
###xml 1559 1566 1559 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23 bib24" ref-type="bibr">[23,24]</xref>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 163 168 <span type="species:ncbi:9606">human</span>
###xml 250 255 <span type="species:ncbi:9606">human</span>
###xml 537 542 <span type="species:ncbi:9606">human</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
###xml 829 834 <span type="species:ncbi:9606">human</span>
It has been suggested that CES3, the mouse homolog of human CES1, plays a major role in stimulated and basal lipolysis in mice [7]. To clarify the role of CES1 in human adipose tissue we analyzed basal, stimulated and inhibited lipolysis in isolated human adipocytes and found no differences in samples with low, intermediate, and high CES1 expression. Since differences in CES1 expression were not accompanied by differences in lipolytic activity our data do not provide further support for the idea that CES1 is an important lipase in human adipose tissue. Schweiger et al. recently demonstrated that 95% of the lipolysis in adipose tissue in mice is mediated via ATGL and HSL [18], thereby also questioning the importance of other lipases such as CES1. Studies on the main lipases, HSL and ATGL, show that their regulation in human adipose tissue differs from the regulation of CES1. HSL expression is reduced in obesity [19-22] and the expression is increased after weight reduction [19]. ATGL expression on the other hand is not different in adipose tissue from obese compared to lean subjects and it is not affected by weight reduction [19]. In both the VLCD study and in the Sib Pair Study, CES1 expression in adipose tissue correlated with metabolic parameters, including total cholesterol, LDL-C, and HDL-C. Interestingly, it has been suggested that CES1, addition to its proposed lipolytic activities, also affects a variety of endogenous cholesterol metabolism pathways, including cholesterol esterification and hydrolyzation of cholesterol esters [23,24]. However, further studies are needed to determine if the associations between CES1 expression and plasma lipid levels are linked to effects of CES1 on cholesterol metabolism.
###end p 37
###begin p 38
###xml 353 358 <span type="species:ncbi:9606">human</span>
We conclude that the expression of CES1 is associated with body fat and adipocyte fat content. However, CES1 expression was not associated with the lipolytic activity in isolated adipocytes. Taken together, our data show that increased CES1 expression is associated with obesity and markers of metabolic dysfunction indicating that CES1 plays a role in human metabolism, however, the mechanisms are unclear.
###end p 38
###begin p 39
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Disclosure statement:</italic>
Disclosure statement: M.J., B.O, P.A, P.J, L.S, A.W, P.F, P.G.M, J.H., and L.M.S.C. have nothing to declare.
###end p 39
###begin title 40
Acknowledgements
###end title 40
###begin p 41
This work was supported by grants from The Swedish Research Council (K2007-55X11285-13-3, K2009-65X-15424-05), Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research, the Swedish Diabetes Foundation, Dr. P. Hakanssons Foundation, the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research, and the Swedish Federal Government under the LUA/ALF agreement, the Royal Physiographic Society (Nilsson-Ehle Foundation), the Foundations of the National Board of Health and Welfare, the Ake Wiberg Foundation, Torsten and Ragnar Soderberg Foundation, the Arosenius Foundation, the Jeansson Foundations, the Tore Nilsson Foundation for Medical Research, the Magnus Bergvall Foundation and the Wellcome Trust (GR079534).
###end p 41
###begin title 42
References
###end title 42
###begin article-title 43
The metabolic syndrome
###end article-title 43
###begin article-title 44
Beneficial health effects of modest weight loss
###end article-title 44
###begin article-title 45
Effects of bariatric surgery on mortality in Swedish obese subjects
###end article-title 45
###begin article-title 46
Millennium fat-cell lipolysis reveals unsuspected novel tracks
###end article-title 46
###begin article-title 47
###xml 31 36 <span type="species:ncbi:9606">human</span>
The role of neutral lipases in human adipose tissue lipolysis
###end article-title 47
###begin article-title 48
The mammalian carboxylesterases: from molecules to functions
###end article-title 48
###begin article-title 49
Carboxylesterase 3 (EC 3.1.1.1) is a major adipocyte lipase
###end article-title 49
###begin article-title 50
###xml 44 49 <span type="species:ncbi:9606">human</span>
Adipocyte triglyceride lipase expression in human obesity
###end article-title 50
###begin article-title 51
Relations of adipose tissue CIDEA gene expression to basal metabolic rate, energy restriction, and obesity: population-based and dietary intervention studies
###end article-title 51
###begin article-title 52
Dissociation between adipose tissue expression and serum levels of adiponectin during and after diet-induced weight loss in obese subjects with and without the metabolic syndrome
###end article-title 52
###begin article-title 53
###xml 58 63 <span type="species:ncbi:9606">human</span>
Depot-specific expression of fibroblast growth factors in human adipose tissue
###end article-title 53
###begin article-title 54
###xml 62 67 <span type="species:ncbi:9606">human</span>
The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss, and correlates with adiposity, insulin sensitivity, and markers of liver dysfunction
###end article-title 54
###begin article-title 55
###xml 14 19 <span type="species:ncbi:9606">human</span>
Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression
###end article-title 55
###begin article-title 56
Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives
###end article-title 56
###begin article-title 57
Automatic luminometric kinetic assay of glycerol for lipolysis studies
###end article-title 57
###begin article-title 58
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
###end article-title 58
###begin article-title 59
Hypothesis testing of regression parameters in semiparametric generalized linear models for cluster correlated data
###end article-title 59
###begin article-title 60
Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism
###end article-title 60
###begin article-title 61
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human adipose triglyceride lipase (PNPLA2) is not regulated by obesity and exhibits low in vitro triglyceride hydrolase activity
###end article-title 61
###begin article-title 62
###xml 77 82 <span type="species:ncbi:9606">human</span>
Hormone-sensitive lipase expression and activity in relation to lipolysis in human fat cells
###end article-title 62
###begin article-title 63
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Hormone-sensitive lipase is reduced in the adipose tissue of patients with type 2 diabetes mellitus: influence of IL-6 infusion
###end article-title 63
###begin article-title 64
###xml 65 70 <span type="species:ncbi:9606">human</span>
Evidence for an important role of perilipin in the regulation of human adipocyte lipolysis
###end article-title 64
###begin article-title 65
###xml 43 48 <span type="species:ncbi:9606">human</span>
Purification, cloning, and expression of a human enzyme with acyl coenzyme A: cholesterol acyltransferase activity, which is identical to liver carboxylesterase
###end article-title 65
###begin article-title 66
###xml 68 73 <span type="species:ncbi:9606">human</span>
Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1
###end article-title 66
###begin article-title 67
###xml 57 62 <span type="species:ncbi:9606">human</span>
A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A
###end article-title 67
###begin article-title 68
###xml 14 19 <span type="species:ncbi:9606">human</span>
Regulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissue
###end article-title 68
###begin p 69
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 648 649 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 519 524 <span type="species:ncbi:9606">women</span>
Regulation of CES1 expression in human adipose tissue. (A) Adipose tissue CES1 expression during diet-induced weight loss measured by DNA microarray analysis (n = 24). (B) Adipose tissue CES1 expression during diet-induced weight loss measured by real-time PCR (n = 10). (C) CES1 expression in adipose tissue of obese and lean siblings (12 pairs of brothers and 78 pairs of sisters) measured by DNA microarray analysis. (D) CES1 expression in paired abdominal and omental adipose tissue samples from 5 obese and 5 lean women measured by DNA microarray analysis. (E) CES1 expression in isolated small and large adipocytes measured by real-time PCR (n = 5).
###end p 69
###begin p 70
Relation between CES1 expression and lipolysis in isolated adipocytes. Basal lipolysis (A), maximal noradrenaline-stimulated lipolysis (B), 8b-cAMP-mediated lipolysis (C), and 8b-cAMP + insulin-inhibited lipolysis (D) in samples with high, intermediate, and low CES1 mRNA levels measured by real-time PCR.
###end p 70
###begin p 71
###xml 23 31 <span type="species:ncbi:9606">patients</span>
Characteristics of the patients included in the VLCT study and association of CES1 expression, analyzed by DNA microarray, with anthropometric measurements and metabolic parameters during diet-induced weight loss.
###end p 71
###begin p 72
###xml 370 371 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 464 477 464 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10 bib12 bib25 bib26" ref-type="bibr">[10,12,25,26]</xref>
BMI, body mass index; WHR; waist hip ratio; TAT, total adipose tissue; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; S-BP, systolic blood pressure; D-BP, diastolic blood pressure; F-glucose, fasting plasma glucose; C, cholesterol; LDL, low density lipoprotein; HD, high density lipoprotein; TG, triglyceride; hs-CRP, high sensitive C-reactive protein, n = 24. The clinical characteristics of subjects in the VLCD study have been described before [10,12,25,26].
###end p 72
###begin p 73
Correlations between adipose tissue CES1 expression and anthropometric and biochemical parameters in the SOS Sib Pair Study.
###end p 73
###begin p 74
###xml 280 281 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
BMI, body mass index; WHR, waist hip ratio; S-BP, systolic blood pressure; D-BP, diastolic blood pressure; F-glucose, fasting plasma glucose; C, cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein; TG, triglyceride; hs-CRP, high sensitive C-reactive protein, n = 357.
###end p 74

